Detection and localization of surgically resectable cancers with a multi-analyte blood test JD Cohen, L Li, Y Wang, C Thoburn, B Afsari, L Danilova, C Douville, ... Science 359 (6378), 926-930, 2018 | 2408 | 2018 |
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development J Wu, H Matthaei, A Maitra, M Dal Molin, LD Wood, JR Eshleman, ... Science translational medicine 3 (92), 92ra66-92ra66, 2011 | 855 | 2011 |
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways J Wu, Y Jiao, M Dal Molin, A Maitra, RF De Wilde, LD Wood, JR Eshleman, ... Proceedings of the National Academy of Sciences 108 (52), 21188-21193, 2011 | 665 | 2011 |
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers JD Cohen, AA Javed, C Thoburn, F Wong, J Tie, P Gibbs, CM Schmidt, ... Proceedings of the National Academy of Sciences 114 (38), 10202-10207, 2017 | 542 | 2017 |
A combination of molecular markers and clinical features improve the classification of pancreatic cysts S Springer, Y Wang, M Dal Molin, DL Masica, Y Jiao, I Kinde, A Blackford, ... Gastroenterology 149 (6), 1501-1510, 2015 | 446 | 2015 |
A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? JK Law, A Ahmed, VK Singh, VS Akshintala, MT Olson, SP Raman, SZ Ali, ... Pancreas 43 (3), 331-337, 2014 | 370 | 2014 |
Targeted next‐generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas E Amato, M Molin, A Mafficini, J Yu, G Malleo, B Rusev, M Fassan, ... The Journal of pathology 233 (3), 217-227, 2014 | 351 | 2014 |
Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages J Yu, AL Blackford, M Dal Molin, CL Wolfgang, M Goggins Gut 64 (11), 1783-1789, 2015 | 229 | 2015 |
Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas M Dal Molin, H Matthaei, J Wu, A Blackford, M Debeljak, N Rezaee, ... Annals of surgical oncology 20, 3802-3808, 2013 | 183 | 2013 |
miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts H Matthaei, D Wylie, MB Lloyd, M Dal Molin, J Kemppainen, SC Mayo, ... Clinical cancer research 18 (17), 4713-4724, 2012 | 162 | 2012 |
A multimodality test to guide the management of patients with a pancreatic cyst S Springer, DL Masica, M Dal Molin, C Douville, CJ Thoburn, B Afsari, L Li, ... Science translational medicine 11 (501), eaav4772, 2019 | 141 | 2019 |
Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas H Matthaei, AL Norris, AC Tsiatis, K Olino, SM Hong, M Dal Molin, ... Annals of surgery 255 (2), 326-333, 2012 | 135 | 2012 |
Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma JK Ryu, H Matthaei, M Dal Molin, SM Hong, MI Canto, RD Schulick, ... Pancreatology 11 (3), 343-350, 2011 | 127 | 2011 |
Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries SR Knight, CA Shaw, R Pius, TM Drake, L Norman, AO Ademuyiwa, ... The Lancet 397 (10272), 387-397, 2021 | 123 | 2021 |
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer G Genovese, A Carugo, J Tepper, FS Robinson, L Li, M Svelto, L Nezi, ... Nature 542 (7641), 362-366, 2017 | 123 | 2017 |
Targeted DNA sequencing reveals patterns of local progression in the pancreatic remnant following resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas A Pea, J Yu, N Rezaee, C Luchini, J He, M Dal Molin, JF Griffin, H Fedor, ... Annals of surgery 266 (1), 133-141, 2017 | 122 | 2017 |
Bispecific antibodies targeting mutant RAS neoantigens J Douglass, EHC Hsiue, BJ Mog, MS Hwang, SR DiNapoli, AH Pearlman, ... Science immunology 6 (57), eabd5515, 2021 | 117 | 2021 |
Very long-term survival following resection for pancreatic cancer is not explained by commonly mutated genes: results of whole-exome sequencing analysis M Dal Molin, M Zhang, RF De Wilde, NA Ottenhof, N Rezaee, ... Clinical Cancer Research 21 (8), 1944-1950, 2015 | 114 | 2015 |
Intraductal papillary mucinous neoplasms arise from multiple independent clones, each with distinct mutations CG Fischer, VB Guthrie, AM Braxton, L Zheng, P Wang, Q Song, JF Griffin, ... Gastroenterology 157 (4), 1123-1137. e22, 2019 | 94 | 2019 |
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer H Matthaei, SM Hong, SC Mayo, M Dal Molin, K Olino, R Venkat, ... Annals of surgical oncology 18, 3493-3499, 2011 | 80 | 2011 |